Valuation: DexCom, Inc.

Market Cap 33.79B 29.27B 27.43B 25.02B 47.03B 3,222B 47.75B 323B 126B 1,613B 127B 124B 5,380B P/E 2026 *
35.9x
P/E 2027 * 30.2x
Enterprise Value 33.02B 28.61B 26.81B 24.45B 45.97B 3,150B 46.68B 315B 123B 1,577B 124B 121B 5,259B EV / Sales 2026 *
6.31x
EV / Sales 2027 * 5.64x
Free-Float
91.27%
Yield 2026 *
-
Yield 2027 * -
1 day+0.95%
1 week+9.56%
Current month+8.52%
1 month+18.61%
3 months+48.12%
6 months+39.15%
Current year+36.45%
1 week 82.09
Extreme 82.09
90.66
1 month 69.79
Extreme 69.79
90.66
Current year 56.72
Extreme 56.72
90.66
1 year 54.11
Extreme 54.11
90.66
3 years 54.11
Extreme 54.11
142
5 years 54.11
Extreme 54.11
164.86
10 years 10.66
Extreme 10.655
164.86
Manager TitleAgeSince
Chief Executive Officer 47 2025-12-31
Director of Finance/CFO 46 2021-03-18
Chief Tech/Sci/R&D Officer - 2024-04-30
Director TitleAgeSince
Chairman 68 2018-07-29
Director/Board Member 67 2009-11-19
Director/Board Member 47 2025-12-31
Date Insider Type Main position Quantity % Market Cap.
8/3/26 Sell

Director

-2,000 0.0005%
7/20/26 Sell

Chairman

-26,756 0.0069%
7/15/26 Sell

General Counsel

-1,700 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
+0.95%+9.56%+12.96%-21.77% 33.79B
+1.16%+5.14%-15.17%+4.75% 190B
+0.05%+5.59%-1.39%+9.19% 116B
-4.38%+0.88%+10.68%+70.56% 63.71B
-0.91%+0.33%+34.28%+58.74% 55.13B
+0.40%+6.66%-6.63%-35.60% 49.41B
+1.06%-3.61% - - 30.74B
+0.06%+0.26%+46.70%-11.99% 24.73B
+0.89%+11.86%-5.01%+19.22% 23.85B
-0.73%+1.57%-3.03%+3.15% 23.23B
Average -0.16%+3.00%+8.15%+10.70% 61.05B
Weighted average by Cap. -0.03%+3.98%+1.04%+12.84%

Financials

2026 *2027 *
Net sales 5.23B 4.53B 4.25B 3.87B 7.28B 499B 7.39B 49.93B 19.52B 250B 19.64B 19.21B 833B 5.8B 5.02B 4.71B 4.29B 8.07B 553B 8.2B 55.37B 21.65B 277B 21.78B 21.3B 924B
Net income 974M 844M 791M 721M 1.36B 92.93B 1.38B 9.3B 3.64B 46.53B 3.66B 3.58B 155B 1.15B 995M 933M 851M 1.6B 110B 1.62B 10.97B 4.29B 54.87B 4.31B 4.22B 183B
Net Debt -761M -659M -618M -564M -1.06B -72.6B -1.08B -7.27B -2.84B -36.35B -2.86B -2.8B -121B -1.06B -920M -862M -786M -1.48B -101B -1.5B -10.13B -3.96B -50.69B -3.99B -3.9B -169B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
26-08-12 US$90.60 +1.20% 3,087,824
26-08-11 US$89.53 +2.14% 5,971,702
26-08-10 US$87.65 +3.42% 7,832,725
26-08-07 US$84.75 +2.08% 4,626,280
26-08-06 US$83.02 +0.44% 3,871,530
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
89.53USD
Average target price
93.44USD
Spread / Average Target
+4.37%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DXCM Stock